6.1.1: Insulin

Part of chapter 6 Endocrine System, section 6.1 Drugs used in diabetes


High-level prescribing trends for Insulin (BNF section 6.1.1) across Dr Jad Weir & Partners for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Biphasic insulin aspart (0601012W0)
Biphasic insulin lispro (0601012F0)
Biphasic isophane insulin (0601012D0)
Insulin aspart (0601011A0)
Insulin degludec (0601012Z0)
Insulin detemir (0601012X0)
Insulin glargine (0601012V0)
Insulin glargine/lixisenatide (0601012AB)
Insulin glulisine (0601011P0)
Insulin human (0601011R0)
Insulin Lispro (0601011L0)
Insulin zinc suspension (0601012G0)
Isophane insulin (0601012S0)
Protamine zinc insulin (0601012U0)
Soluble insulin (Neutral insulin) (0601011N0)

Download raw data

Download CSVs: all data on Insulin or data on Insulin by Sub-ICB Location.

Feedback